Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imuno CD
- Development stage
- Unknown
- Lead developer
- PharmaS
- Administration
- Oral
01
Overview
Imuno CD is a dietary supplement developed and marketed by the Croatian pharmaceutical company PharmaS. It is formulated to support the normal function of the immune system and protect cells from oxidative stress. The product typically contains a high-dose combination of Vitamin C (ascorbic acid), Vitamin D3 (cholecalciferol), and Zinc. Vitamin C and Zinc contribute to the protection of cells from oxidative stress and support the integrity of immune barriers, while Vitamin D3 plays a critical role in modulating both innate and adaptive immune responses. It is part of PharmaS's consumer healthcare portfolio and is commonly available in the form of effervescent tablets.
- Brand names
- Imuno CD
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Imuno CD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imuno CD.